4.7 Article

Risk of Cardiovascular and All-Cause Mortality: Impact of Impaired Health-Related Functioning and Diabetes The Australian Diabetes, Obesity and Lifestyle (AusDiab) study

期刊

DIABETES CARE
卷 35, 期 5, 页码 1067-1073

出版社

AMER DIABETES ASSOC
DOI: 10.2337/dc11-1288

关键词

-

资金

  1. Diabetes UK [09/0003833]
  2. National Health and Medical Research Council (NHMRC) [586623, 233200]
  3. Lions Foundation
  4. Victorian Government
  5. Australian Government Department of Health and Ageing, City Health Centre-Diabetes Service-Canberra
  6. Department of Health and Community Services-Northern Territory
  7. Department of Health and Human Services-Tasmania
  8. Department of Health-New South Wales
  9. Department of Health-Western Australia
  10. Department of Health South Australia
  11. Department of Human Services-Victoria
  12. Diabetes Australia
  13. Diabetes Australia Northern Territory
  14. Estate of the Late Edward Wilson
  15. Jack Brockhoff Foundation
  16. Kidney Health Australia
  17. Marian FH Flack Trust
  18. Menzies Research Institute
  19. Pratt Foundation
  20. Abbott Australasia Pty Ltd
  21. Alphapharm Pty Ltd
  22. AstraZeneca
  23. Bristol-Myers Squibb
  24. Eli Lilly Australia
  25. GlaxoSmithKline
  26. Janssen-Cilag
  27. Merck Sharp Dohme
  28. Novartis Pharmaceuticals
  29. Novo Nordisk Pharmaceuticals
  30. Pfizer Pty Ltd
  31. Queensland Health
  32. Roche Diagnostics Australia
  33. Royal Prince Alfred Hospital (Sydney, New South Wales, Australia)
  34. sanofi-aventis
  35. Sanofi-Synthelabo
  36. Diabetes UK [09/0003833] Funding Source: researchfish

向作者/读者索取更多资源

OBJECTIVE-There is an established link between health-related functioning (HRF) and cardiovascular disease (CVD) mortality, and it is known that those with diabetes predominantly die of CVD. However, few studies have determined the combined impact of diabetes and impaired HRF on CVD mortality. We investigated whether this combination carries a higher CVD risk than either component alone. RESEARCH DESIGN AND METHODS-The Australian Diabetes, Obesity and Lifestyle (AusDiab) study included 111,247 adults aged >= 2.5 years from 42 randomly selected areas of Australia. At baseline (1999-2000), diabetes status was defined using the World Health Organization criteria and HRF was assessed using the SF-36 questionnaire. RESULTS Overall, after 7.4 years of follow-up, 57 persons with diabetes and 105 without diabetes had died from CVD. In individuals with and without diabetes, HRF measures were significant predictors of increased CVD mortality. The CVD mortality risks among those with diabetes or impaired physical health component summary (PCS) alone were similar (diabetes only: hazard ratio 1.4 [95% CI 0.7-2.7]; impaired PCS alone: 1.5 [1.0-2.4]), while those with both diabetes and impaired PCS had a much higher CVD mortality (2.8 [1.6-4.7]) compared with those without diabetes and normal PCS (after adjustment for multiple covariates). Similar results were found for the mental health component summary. CONCLUSIONS This study demonstrates that the combination of diabetes and impaired HRF is associated with substantially higher CVD mortality. This suggests that, among those with diabetes, impaired HRF is likely to be important in the identification of individuals at increased risk of CVD mortality.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据